Related Experiment Videos
It is a good analysis when…: Quality criteria for a reactive analysis following an adverse event
Gianfranco Brusadin1, Margaux Charpentier2, Mathieu Herbez3
1Quality and Risk Management Department, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
Objective:
Although radiation oncology relies heavily on adverse event reporting to improve patient safety, the quality of retrospective analyses remains heterogeneous, often leading to ineffective action plans (retraining, simple reminders to remain vigilant). This article aims to propose criteria defining a high-quality reactive analysis based on the human, social, and organizational factors that determine its effectiveness, regardless of the investigation methodology used (ALARM, ORION, etc.).
Discussion:
Conducting an effective analysis requires, above all, a non-punitive "just culture" and impartial leadership by an expert trained in cognitive biases. The analysis process is broken down into three key steps: an objective and immediate gathering of facts by a neutral person; a multidisciplinary analysis meeting focused on systemic failures rather than individual blame, dedicating most of its time to developing robust corrective actions; and finally, monitoring the deployment. Furthermore, evaluating the effectiveness of these actions cannot be reduced to the simple absence of recurrence, particularly for rare events, and requires the implementation of proactive approaches such as targeted audits or unannounced "stress tests".
Conclusion:
Ultimately, the value of an analysis depends more on the rigor and fairness with which it is conducted than on the specific tool selected. To sustainably improve safety, it is essential to move beyond technological performance alone and embed collective learning and patient safety within the organization's culture and identity. Direct integration of patients into these analytical processes represents the next challenge in advancing shared systemic resilience.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Quality Assurance
Assumptions of Survival Analysis
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Quality Control
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...